Actinomycetales Infections: Clinical Trials

1,977 trials for Actinomycetales Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1258 completed, 297 unknown, 157 recruiting, 84 not yet recruiting. 430 Not applicable, 363 Phase 2, 312 Phase 3, 241 Phase 1, 164 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable430Completed 261, Unknown 75, Recruiting 38, Not yet recruiting 23, Active not recruiting 12, Terminated 9, Withdrawn 7, Enrolling by invitation 3, Suspended 2
Phase 2363Completed 236, Unknown 37, Recruiting 33, Terminated 20, Active not recruiting 12, Not yet recruiting 10, Withdrawn 8, Enrolling by invitation 4, Suspended 3
Phase 3312Completed 222, Unknown 25, Recruiting 23, Active not recruiting 12, Not yet recruiting 11, Terminated 11, Withdrawn 7, Suspended 1
Phase 1241Completed 181, Unknown 17, Recruiting 10, Terminated 10, Not yet recruiting 7, Active not recruiting 6, Withdrawn 6, Enrolling by invitation 3, Suspended 1
Phase 4164Completed 101, Unknown 32, Recruiting 10, Terminated 10, Active not recruiting 4, Not yet recruiting 4, Withdrawn 3
Early Phase 110Completed 6, Not yet recruiting 2, Recruiting 1, Unknown 1

Follow Actinomycetales Infections: new trials by email Literature Review of Actinomycetales Infections trials Research Report on Actinomycetales Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Advanced HIV Re-engagement in Care
ARC - Advanced HIV Disease
Not applicableNot yet recruitingUniversity of Alabama at Birmingham7242027-05-012026-07-23
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
ID93 + GLA-SE vaccine, Placebo vaccine - Tuberculosis, Pulmonary
Phase 2Not yet recruitingAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections15002027-01-312026-08-24
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections
Phase 1 / Phase 2WithdrawnInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group2026-12-312026-08-17
Shaping a Community-based Pathway to Improve TB Surveillance Among African and Hindustan Immigrants Experiencing Vulnerabilities
Tuberculosis, Tuberculosis (TB)
Not yet recruitingUniversidade Nova de Lisboa2002026-12-012026-07-07
Feasibility of Tracheobronchial Reconstruction Using Allogenic Aortic Patch in Children
Cryopreserved aorta - Trachea Diseases, Tracheal Stenosis
Not applicableEnrolling by invitationNational Taiwan University Hospital52026-12-012026-08-17
A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy Adults
VIR-1778 (5 × 10^5 ffu), VIR-1778 (5 × 10^6 ffu), HT Diluent Placebo - Tuberculosis
Phase 1Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)1162026-11-062026-09-14
The LalelaLung Study: Digital Stethoscope Clinical Evaluation
StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary
Phase 4Not yet recruitingJohns Hopkins University3502026-11-022026-09-23
China Aortic Infection and Graft Infection Study: An Ambispective Cohort
Vascular Graft Infection, Infectious Aortitis
RecruitingShanghai Zhongshan Hospital20002026-11-012026-10-02
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
Isoniazid, Rifampin, Pyrazinamide - Tuberculosis
Phase 2Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)9002026-10-302026-08-19
A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine
Previously received the Tdcp vaccine at age 18 and older, Previously received the Tdcp vaccine at age 12-17, Previously received the Tdcp vaccine at age 6-11 - Diphtheria, Tetanus
Not yet recruitingCanSino Biologics Inc.1602026-10-152026-08-04
Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in Uganda
The intervention is TB treatment delivery via community pharmacies for people with TB/HIV, Control Arm - standard of care - TB - Tuberculosis, HIV - Human Immunodeficiency Virus
Not applicableNot yet recruitingMakerere University1242026-10-012026-09-25
Re-evaluating the Duration in Children of TB Treatment
Rifampicin, Isoniazid, Pyrazinamide - Tuberculosis
Phase 2Not yet recruitingUniversity of Wisconsin, Madison2302026-10-012026-09-29
Digital Psychosocial Interventions on Stigma and Health Outcomes in TB Patients
Online Mindfulness, Online CBT Intervention, Human-computer Interaction - Tuberculosis (TB)
Not applicableNot yet recruitingPeking Union Medical College4962026-10-012026-08-03
A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis
MDR-END Plus regimen, Standard-of-care (SoC) treatment - Rifampicin-Resistant Tuberculosis
Phase 3Not yet recruitingSeoul National University Hospital2942026-10-012026-06-30
Study of BK1803 in Healthy Infants
BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria
Phase 3Not yet recruitingTanabe Pharma Corporation3442026-10-012026-08-28
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis
Hydrocortisone administration, Expanded antimicrobial therapy - Sepsis, Tuberculosis
Phase 3Not yet recruitingUniversity of Virginia3442026-10-012026-06-01
Plasma MTB cfDNA Before Bronchoscopy
Diagnostic Test: Plasma MTB cfDNA assay - Tuberculosis Diagnosis
Not yet recruitingChinese University of Hong Kong6002026-10-012025-11-17
Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury.
Antituberculosis drugs Group - Drug-Induced Acute Liver Injury, Tuberculosis (TB)
Early Phase 1Not yet recruitingAssiut University1022026-10-012026-10-21
Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis
[18F]-FAPI-74 - Tuberculosis, Pulmonary
Early Phase 1RecruitingUniversity of Pennsylvania102026-09-302026-09-21

Showing 20 of 1977. Sign in to see all of them.

Narrower conditions

Tuberculosis (1142)  ·  Tuberculosis, Pulmonary (309)  ·  Diphtheria (254)  ·  Tetanus (243)  ·  Latent Tuberculosis (198)  ·  Whooping Cough (160)  ·  HIV Infections (147)  ·  Tuberculosis, Multidrug-Resistant (129)  ·  Acquired Immunodeficiency Syndrome (118)  ·  Poliomyelitis (114)  ·  Hepatitis B (109)  ·  Haemophilus Infections (107)  ·  Mycobacterium avium-intracellulare Infection (66)  ·  Mycobacterium Infections (59)  ·  Mycobacterium Infections, Nontuberculous (54)

Broader conditions

Bacterial Infections and Mycoses (1975)  ·  Gram-Positive Bacterial Infections (1972)  ·  Bacterial Infections (1958)  ·  Infections (1958)  ·  Mycobacterium Infections (1655)  ·  Respiratory Tract Diseases (589)  ·  Respiratory Tract Infections (515)  ·  Virus Diseases (393)  ·  Tuberculosis (390)  ·  Lung Diseases (384)  ·  RNA Virus Infections (360)  ·  Blood-Borne Infections (328)  ·  Communicable Diseases (326)  ·  Immune System Diseases (271)

Interventions

Isoniazid (166)  ·  Rifampin (141)  ·  Pyrazinamide (92)  ·  Ethambutol (87)  ·  bedaquiline (69)  ·  Moxifloxacin (56)  ·  rifapentine (53)  ·  Tetanus Toxoid (50)  ·  Linezolid (48)  ·  pretomanid (38)  ·  Rifabutin (36)  ·  OPC-67683 (34)  ·  Clofazimine (31)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (29)  ·  Levofloxacin (27)

Sponsors

GlaxoSmithKline (116)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (113)  ·  Sanofi Pasteur, a Sanofi Company (58)  ·  University of Oxford (39)  ·  Johns Hopkins University (37)  ·  Global Alliance for TB Drug Development (31)  ·  Centers for Disease Control and Prevention (29)  ·  University of Cape Town (28)  ·  National Taiwan University Hospital (24)  ·  Aeras (23)  ·  Beijing Chest Hospital (22)  ·  Sanofi (20)  ·  Seoul National University Hospital (20)  ·  Assistance Publique - Hôpitaux de Paris (19)  ·  Huashan Hospital (18)

Countries

South Africa (284)  ·  United States (280)  ·  China (140)  ·  Uganda (107)  ·  India (102)  ·  South Korea (88)  ·  United Kingdom (82)  ·  Brazil (71)  ·  Tanzania (61)  ·  Canada (56)  ·  France (56)  ·  Indonesia (56)  ·  Thailand (56)  ·  Taiwan (54)  ·  Philippines (51)

Top investigators

Helen McShane (20)  ·  Nicholas Paton (10)  ·  Clifton E Barry, Ph.D. (8)  ·  Jae-Joon Yim, MD (8)  ·  Susan Dorman, MD (8)  ·  Andreas Diacon, MD (6)  ·  Chin-Chung Shu, MD (6)  ·  Grant Theron, PhD (6)  ·  Marc Weiner, MD (6)  ·  Dick Menzies, MD (5)

Results publications

PMID 33616229, PMID 40122135, PMID 25466778, PMID 36808186, PMID 28043488, PMID 28063795, PMID 33542052, PMID 17716936, PMID 17957238, PMID 19529780, PMID 19880906, PMID 20442432, PMID 20629533, PMID 21215445, PMID 22150035, PMID 23691171, PMID 23979737, PMID 24675585, PMID 24874401, PMID 25114140, PMID 25359354, PMID 25882172, PMID 25904367, PMID 26400476, PMID 26647431, PMID 27097163, PMID 27243774, PMID 27868466, PMID 28216183, PMID 28340322, PMID 29393655, PMID 30102705, PMID 30216086, PMID 31866327, PMID 32539440, PMID 32785709, PMID 32934758, PMID 33283229, PMID 33595792, PMID 34021314, PMID 34929010, PMID 35404075, PMID 35850123, PMID 36053506, PMID 36546625, PMID 36560565, PMID 36730240, PMID 36949623, PMID 37035978, PMID 37980911

NIH funding

2009 (6), 2014 (6), R01HD071779 (6), 2017 (4), 2023 (4), U01AI068636 (4), UM1AI068636 (4), 2005 (3), 2008 (3), 2015 (3), 2019 (3), 5UL1RR024982-02 (3), U01AI152087 (3), 2016 (2), D43TW009127 (2)